EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Use of Deferred Consent in Randomized Clinical Trials

Jessie Van Leeve, Michael Colacci

NEJM Evidence · 24.03.2026 · 5 (4)

DOI: 10.1056/evidctw2400266 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift NEJM Evidence, erschienen am 24.03.2026. Verfasst von Jessie Van Leeve und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ethics Quality Improvement Lab, William Osler Health System, Brampton, ON, Canada. Hauptthemen laut MEDLINE: Informed Consent, Randomized Controlled Trials as Topic, Patient Selection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractGood clinical practice standards mandate that informed consent be obtained before enrollment for all trials that present more than minimal risk to participants. Deferred consent, the process of enrolling patients in a clinical trial before consent is obtained, is sometimes employed in emergency care settings when patients are unable to consent at the time of trial enrollment, are critically ill, and a delay in enrollment would preclude them from potentially benefiting from the trial treatment. This article reviews the risks and benefits associated with the use of deferred consent in randomized controlled trials and the ethical acceptability of its use within specific clinical trial contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Informed ConsentRandomized Controlled Trials as TopicPatient SelectionHumans

Autor:innen und Institutionen

  • Ethics Quality Improvement Lab, William Osler Health System, Brampton, ON, Canada.
  • Center for Bioethics, Harvard Medical School, Boston, MA, USA.
  • Division of Internal Medicine, University of Toronto Faculty of Medicine, Toronto, ON, Canada.
  • Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Zitieren

APA

Van Leeve, J., & Colacci, M. (2026). Use of Deferred Consent in Randomized Clinical Trials. NEJM Evidence, 5(4). https://doi.org/10.1056/evidctw2400266

Vancouver

Van Leeve J, Colacci M. Use of Deferred Consent in Randomized Clinical Trials. NEJM Evidence. 2026;5(4). doi:10.1056/evidctw2400266

BibTeX
@article{VanLeeve2026,
  author = {Van Leeve, Jessie and Colacci, Michael},
  title = {Use of Deferred Consent in Randomized Clinical Trials},
  journal = {NEJM Evidence},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1056/evidctw2400266}
}
Kostenlos starten →